Effective Measurement of Risperidone Treatment Outcome for Persons With Borderline Personality Disorder

Clinical trial NCT00204347 · COMPLETED

Trial details

NCT number: NCT00204347
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Borderline Personality Disorder

Start date: 2003-07-01
Primary completion: 2007-10-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.